Khattab S, Askar A, Abdellatif H, Othman A, Rayan A, Azab H
Sci Rep. 2025; 15(1):5102.
PMID: 39934194
PMC: 11814154.
DOI: 10.1038/s41598-025-88965-7.
Assefa G, Roberts J, Aslan A, Mohammed S, Sime F
J Antimicrob Chemother. 2024; 80(2):334-346.
PMID: 39691958
PMC: 11787894.
DOI: 10.1093/jac/dkae451.
Hidalgo-Tenorio C, Bou G, Oliver A, Rodriguez-Aguirregabiria M, Salavert M, Martinez-Martinez L
Drugs. 2024; 84(12):1519-1539.
PMID: 39467989
PMC: 11652570.
DOI: 10.1007/s40265-024-02102-8.
Khan S, Das A, Vashisth D, Mishra A, Vidyarthi A, Gupta R
PLoS One. 2024; 19(5):e0303753.
PMID: 38758757
PMC: 11101023.
DOI: 10.1371/journal.pone.0303753.
Emilie C, Alice C, Marine G, Farfour E, Pourbaix A, Dortet L
Eur J Clin Microbiol Infect Dis. 2024; 43(4):777-784.
PMID: 38277033
DOI: 10.1007/s10096-024-04766-2.
Evaluation of Aztreonam and Ceftazidime/Avibactam Synergism against by MALDI-TOF MS.
Wilhelm C, Inamine E, Martins A, Barth A
Antibiotics (Basel). 2023; 12(6).
PMID: 37370382
PMC: 10295265.
DOI: 10.3390/antibiotics12061063.
Synthesis and biological evaluation of novel β-lactam-metallo β-lactamase inhibitors.
Shungube M, Hlophe A, Girdhari L, Sabe V, Peters B, Reddy N
RSC Adv. 2023; 13(28):18991-19001.
PMID: 37362332
PMC: 10285615.
DOI: 10.1039/d3ra02490c.
Ceftazidime-Avibactam plus aztreonam synergistic combination tested against carbapenem-resistant Enterobacterales characterized phenotypically and genotypically: a glimmer of hope.
Taha R, Kader O, Shawky S, Rezk S
Ann Clin Microbiol Antimicrob. 2023; 22(1):21.
PMID: 36945002
PMC: 10029209.
DOI: 10.1186/s12941-023-00573-3.
Management of clinical infections of by new β-lactam/β-lactamase inhibitor combinations.
Kadry A, El-Antrawy M, El-Ganiny A
Iran J Microbiol. 2023; 14(4):466-474.
PMID: 36721515
PMC: 9867644.
DOI: 10.18502/ijm.v14i4.10232.
In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant and .
Mantzana P, Protonotariou E, Kassomenaki A, Meletis G, Tychala A, Keskilidou E
Antibiotics (Basel). 2023; 12(1).
PMID: 36671295
PMC: 9855173.
DOI: 10.3390/antibiotics12010093.
In vitro and in vivo Antimicrobial Activities of Ceftazidime/Avibactam Alone or in Combination with Aztreonam Against Carbapenem-Resistant Enterobacterales.
Lu G, Tang H, Xia Z, Yang W, Xu H, Liu Z
Infect Drug Resist. 2022; 15:7107-7116.
PMID: 36506837
PMC: 9733440.
DOI: 10.2147/IDR.S385240.
Resistance to aztreonam-avibactam due to CTX-M-15 in the presence of penicillin-binding protein 3 with extra amino acids in .
Ma K, Zong Z
Front Microbiol. 2022; 13:1047109.
PMID: 36406430
PMC: 9674307.
DOI: 10.3389/fmicb.2022.1047109.
Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy Adults.
Lodise T, ODonnell J, Balevic S, Liu X, Gu K, George J
Antimicrob Agents Chemother. 2022; 66(12):e0093622.
PMID: 36394326
PMC: 9764983.
DOI: 10.1128/aac.00936-22.
Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers.
Lodise T, ODonnell J, Raja S, Guptill J, Zaharoff S, Schwager N
Antimicrob Agents Chemother. 2022; 66(12):e0093522.
PMID: 36394316
PMC: 9764989.
DOI: 10.1128/aac.00935-22.
The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic.
Reynolds D, Burnham J, Guillamet C, McCabe M, Yuenger V, Betthauser K
Eur Respir Rev. 2022; 31(166).
PMID: 36261159
PMC: 9724833.
DOI: 10.1183/16000617.0068-2022.
A Case of New Delhi Metallo-β-Lactamases (NDM) Citrobacter sedlakii Osteomyelitis Successfully Treated With Ceftazidime-Avibactam and Aztreonam.
Rubnitz Z, Kunkel V, Baselski V, Summers N
Cureus. 2022; 14(9):e28855.
PMID: 36225496
PMC: 9536843.
DOI: 10.7759/cureus.28855.
Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion.
Coppola N, Maraolo A, Onorato L, Scotto R, Calo F, Atripaldi L
Antibiotics (Basel). 2022; 11(9).
PMID: 36140042
PMC: 9495208.
DOI: 10.3390/antibiotics11091263.
β-Lactam Antibiotics and β-Lactamase Enzymes Inhibitors, Part 2: Our Limited Resources.
Alfei S, Schito A
Pharmaceuticals (Basel). 2022; 15(4).
PMID: 35455473
PMC: 9031764.
DOI: 10.3390/ph15040476.
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics.
Murugaiyan J, Kumar P, Rao G, Iskandar K, Hawser S, Hays J
Antibiotics (Basel). 2022; 11(2).
PMID: 35203804
PMC: 8868457.
DOI: 10.3390/antibiotics11020200.
Combination antibiotic therapy for treatment of a patient with infected prosthesis and peri-prosthetic abscess due to harboring New Delhi Metallo (NDM) beta-lactamase.
Cespedes Santana M, Wong T, Urban C, Mariano N, Burns J, Rodriguez G
IDCases. 2022; 27:e01385.
PMID: 35070715
PMC: 8762063.
DOI: 10.1016/j.idcr.2022.e01385.
